You just read:

Regeneron Provides Update on EYLEA® (aflibercept) Injection and Nesvacumab (Ang2 Antibody) Combination Program

News provided by

Regeneron Pharmaceuticals, Inc.

Nov 27, 2017, 01:00 ET